Interferon-induced human protein in pure form, monoclonal...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/37, 195/1.1,

C12N 5/20 (2006.01) C07K 1/22 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12N 15/06 (2006.01) C12P 21/08 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1340289

The invention relates to purified proteins induced in human cells by interferon .alpha. or .beta., RNAs, DNAs and hybrid vectors coding for said proteins, hosts transformed with such a hybrid vector, processes for the preparation and purification of these proteins, DNAs, vectors and hosts, monoclonal antibodies specific to these proteins, monoclonal antibody derivatives, hybridoma cell lines secreting these monoclonal antibodies, the use of the monoclonal antibodies and their derivatives in the qualitative and quantitative determination of these proteins, test kits containing the monoclonal antibodies, and pharmaceutical preparations containing said proteins. A protein of the invention shows antiviral properties ascribed to interferons and may be a valuable indicator of the cell response to an interferon therapy.

534493

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interferon-induced human protein in pure form, monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon-induced human protein in pure form, monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon-induced human protein in pure form, monoclonal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1225258

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.